Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121

Annals of Thoracic Surgery

Volumn 69, Issue 1, 2000, Pages 14-23

  Lee, Leonard Y ^a   Patel, Shailen R ^a   Hackett, Neil R ^a   MacK, Charles A ^a   Polce, Dean R ^a   El Sawy, Tarek ^a   Hachamovitch, Rory ^a   Zanzonico, Pat ^a   Sanborn, Timothy A ^a   Parikh, Manish ^a   Isom, O Wayne ^a   Crystal, Ronald G ^a   Rosengart, Todd K ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CLONING VECTOR; CONFERENCE PAPER; CONTROLLED STUDY; GENE THERAPY; HEART MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SWINE;

EID: 0033971692     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01102-9     Document Type: Conference Paper

References (26)

1. Trends in ischemic heart disease deaths - United States, 1990-1994. JAMA. 277:1997;1109.
2. Rosengart T.K., Patel S.R., Crystal R.G. Therapeutic angiogenesis protein and gene therapy delivery strategies . J Cardio Vasc Risk. 8:1999;29-40.
3. Hockel M., Schlenger K., Doctrow S., Kissel T., Vaupel P. Therapeutic angiogenesis. Arch Surg. 128:1993;423-429.
4. Giordano F.J., Ping P., McKirnan M.D., et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2:1996;534-539.
5. Lazarous D.F., Shou M., Scheinowitz M., et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 94:1996;1074-1082.
6. Sellke F.W., Li J., Stamler A., Lopez J.J., Thomas K.A., Simons M. Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery. 120:1996;182-188.
7. Mack C.A., Patel S.R., Schwarz E.A., et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg. 115:1998;168-177.
8. Gospodarowicz D., Abraham J.A., Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA. 86:1989;7311-7315.
9. Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., Leung D.W. The vascular endothelial growth factor family identification of a fourth molecular species and characterization of alternative splicing of RNA . Mol Endocrinol. 5:1991;1806-1814.
10. Olofsson B., Pajusola K., Kaipainen A., et al. Vascular endothelial growth factor b, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA. 93:1996;2576-2581.
11. Chilov D., Kukk E., Taira S., et al. Genomic organization of human and mouse genes for vascular endothelial growth factor c. J Biol Chem. 272:1997;25176-25183.
12. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 5:1990;519-524.
13. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 13:1992;18-32.
14. Magovern C.J., Mack C.A., Zhang J., et al. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann Thorac Surg. 62:1996;425-434.
15. 165 in patient with ischaemic limb. Lancet. 348:1996;370-374.
16. Hersh J., Crystal R.G., Bewig B. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2:1995;124-131.
17. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
18. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count a quantitative method of assessing coronary artery flow . Circulation. 93:1996;879-888.
19. Hachamovitch R., Berman D.S., Kiat H., et al. Exercise myocardial perfusion spect in patients without known coronary artery disease incremental prognostic value and use in risk stratification . Circulation. 93:1996;905-914.
20. Yang R.H., Thomas G.R., Bunting S., et al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol. 27:1996;838-844.
21. Crystal R.G. Transfer of genes to humans early lessons and obstacles to success . Science. 270:1995;404-410.
22. Anderson W.F. Human gene therapy. Science. 256:1992;808-813.
23. Wilson J.M. Adenoviruses as gene-delivery vehicles. N Engl J Med. 334:1996;1185-1187.
24. Springer M.L., Chen A.S., Kraft P.E., Bednarski M., Blau H.M. VEGF gene delivery to muscle potential role for vasculogenesis in adults . Mol Cell. 2:1998;549-558.
25. Patel S.R., Lee L.Y., Mack C.A., et al. Safety of direct myocardial administration of an adenovirus vector coding for vascular endothelial growth factor 121. Hum Gene Ther. 11:1999;1331-1348.
26. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1:1995;27-31.